Case report| Volume 91, ISSUE 1, P91-92, January 2015

Delayed-type hypersensitivity reaction against Nexplanon®


      Nexplanon® is an etonogestrel implant with a long-acting contraceptive effect. Although several studies underlined its safety profile, its implant can rarely lead to moderate or severe adverse event. Here, we presented a case of delayed-type hypersensitivity reaction against Nexplanon® that resolved after its removal.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mommers E.
        • Blum G.F.
        • Gent T.G.
        • Peters K.P.
        • Sørdal T.S.
        • Marintcheva-Petrova M.
        Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial.
        Am J Obstet Gynecol. 2012; 207: 388.e1-388.e6
        • Mark A.
        • Sonalkar S.
        • Borgatta L.
        One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
        Contraception. 2013; 88: 619-623
        • Black C.A.
        Delayed type hypersensitivity: current theories with an historic perspective.
        Dermatol Online J. 1999; 5: 7
        • Niederhauser A.
        • Magann E.F.
        • Hoffman K.
        An allergic reaction to Implanon placement and review of the literature.
        J Ark Med Soc. 2011; 108: 92
        • Sullivan M.J.
        Allergy to nexplanon®.
        J Fam Plann Reprod Health Care. 2012; 38: 272